期刊文献+

血流储备分数在指导冠状动脉多支病变治疗策略中的作用 被引量:6

Role of fractional flow reserve in guiding percutaneous coronary intervention in patients with multivessel coronary disease
下载PDF
导出
摘要 目的评估冠状动脉造影筛选的冠状动脉多支病变与心肌缺血的关系,阐明血流储备分数(FFR)在指导冠状动脉多支病变治疗策略中的作用。方法纳入96例患者218处冠状动脉病变,根据FFR值分为两组,FFR>0.80组(113处)及FFR≤0.80组(105处)。结果 FFR≤0.80组冠状动脉直径狭窄程度更高[(66.2±10.5)%比(59.1±13.8)%,P<0.001]、面积狭窄百分比更大[(87.3±7.7)%比(81.4±10.9)%,P<0.001]、最小管腔直径更小[(0.86±0.36)mm比(1.18±0.49)mm,P<0.001],上述指标与FFR值无明确相关(相关系数分别为r=-0.286,P<0.001;r=-0.282,P<0.001)。冠状动脉最小管腔直径与FFR值呈正相关(r=0.364,P<0.001)。冠状动脉造影筛选的96例患者中,26例为三支病变,70例为双支病变;经FFR测量后,缺血相关的三支病变10例,两支病变29例,单支病变17例。QCA冠状动脉造影直径狭窄≥70%,FFR>0.80的病变为21处(9.6%);QCA冠状动脉造影直径狭窄<70%,FFR≤0.80的病变为53处(24.3%)。QCA冠状动脉造影直径狭窄≥70%,FFR≤0.80的病变为52处(23.9%)(Matches);QCA冠状动脉造影直径狭窄<70%,FFR>0.80的病变为92处(42.2%)(Matches)。QCA冠状动脉造影面积狭窄≥70%,FFR>0.80的病变为89处(40.8%)(Mismatches);QCA冠状动脉造影面积狭窄≥70%,FFR≤0.80的病变为105处(48.2%)(Matches);QCA冠状动脉造影面积狭窄<70%,FFR>0.80的病变为24处(11.0%)(Matches)。结论 FFR在指导冠状动脉多支病变治疗策略中具有重要意义,可显著降低缺血相关靶病变个数。 Objective To explore the correlation between quantitative coronary angiography(QCA) parameters and fractional flow reserve (FFR) value. To illustrate the role of FFR in guiding PCI in patients with multivessel coronary artery disease. Methods This study included 96 patients with 218 coronary artery lesions. Patients were divided into two groups: FFR 〉 0.80 (n = 113 ) or FFR ≤0. 80 (n = 105 ). Results There were significant statistical difference of percentage diameter stenosis [ ( 59. 1% ±13.8% ) vs. (66.2% ±10.5%, P〈0.001] and percentage areastenosis [(81.4% ±10.9%) vs. (87.3% ±7.7%, P 〈 0. 001 ] between groups. Percentage diameter stenosis and percentage area stenosis were not correlated with FFR value ( r=-0. 286, P 〈 0. 001, r = - 0. 282, P 〈 0. 001 ). The minimum luminal diameter was statistically different between groups [ ( 1.18±0. 49 )mm vs. ( 0. 86 ± 0. 36 ) mm, P 〈 0. 001 ] and positively correlated with FFR value (r =0. 364 ,P 〈0. 001 ). QCA detected 26 patients with three vessel disease and 70 patients with two vessel disease. However, FFR value suggested that only 10 patients had three vessel disease, 29 patients had two vessel disease and 17 patients had one vessel disease. Mismatches and reverse mismatches between diameter stenosis(QCA) and FFR value were 21 (9. 6% ), 53 (24. 3% ), respectively. Mismatches between area stenosis (QCA) and FFR value was 89 (40. 8%). Conclusions FFR measurement in patients with multivesselcoronary disease significantly reduces target lesions when compared with standard angiography-guidedPCI.
出处 《中国介入心脏病学杂志》 2013年第5期279-283,共5页 Chinese Journal of Interventional Cardiology
关键词 冠状动脉疾病 血流储备分数 血管造影术 Coronary artery disease Fractional flow reserve Angiography
  • 引文网络
  • 相关文献

参考文献15

  • 1Moses JW, Stone GW, Nikolsky E, et al. Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials. J Am Coil Cardiol, 2006, 47:2164-2171.
  • 2Pijls NH,van Son JA, Kirkeeide RL, et al. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation, 1993, 87:1354-1367.
  • 3Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med, 1996, 334:1703-1708.
  • 4De Bruyne B, Sarma J. Fractional flow reserve: a review: invasive imaging. Heart, 2008, 94:949-959.
  • 5Pijls NH, van Sehaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol, 2007, 49:2105-2111.
  • 6Courtis J, Rodrs-Cahau J, Larose E, et al. Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses. Am J Cardiol, 2009, 103:943-949.
  • 7Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding pereutaneous coronary intervention. N Engl J Med, 2009, 360:213-224.
  • 8De Bruyne B, Pijls NH, Bartunek J, et al. Fractional flow reserve in patients with prior myocardial infarction. Circulation, 2001, 104 : 157-162.
  • 9McClish JC, Ragosta M, Powers ER, et al. Effect of acute myocardial infarction on the utility of fractional flow reserve for the physiologic assessment of the severity of coronary artery narrowing. Am J Cardiol, 2004, 93:1102-1106.
  • 10Berger A, Botman KJ, MacCarthy PA, et al. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. J Am Call Cardiol, 2005,46:438-442.

同被引文献92

  • 1Kohichiro Iwasaki.Myocardial ischemia is a key factor in the management of stable coronary artery disease[J].World Journal of Cardiology,2014,6(4):130-139. 被引量:13
  • 2韩雅玲,李成洋,王效增,荆全民,王守力,马颖艳,栾波,王祖禄,王冬梅.多支冠状动脉病变完全及不完全介入性血运重建1年疗效的比较[J].解放军医学杂志,2006,31(6):512-514. 被引量:5
  • 3Lee BK, Choi HH, Hong KS, et al. Efficacy of fractional flow reserve measurements at side branch vessels treated with the crush stenting technique in true coronary bifurcation lesions J ]. Clin Cardiol, 2010,33 ( 8 ) :490-494.
  • 4Pijls NH, van Sehaardenburgh P, Manoharan G, et al. Percutane- ous coronary intervention of functionally nonsignificant stenosis: 5- year follow-up of the DEFER Study[ J]. J Am Coll Cardiol,2007, 49(21 ) :2105-2111.
  • 5Courtis J, Rodos-Cabau J, Larose E, et al. Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses [ J ]. Am J Cardio1,2009,103 ( 7 ) :943-949.
  • 6Applegate RJ. Fractional flow reserve guided stent therapy for mul- tivessel disease : taking a closer look [ J]. J Am Coil Cardiol,2010, 55 ( 25 ) :2822-2824.
  • 7Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention [J]. N Engl J Meal,2009, 360(3) :213-224.
  • 8Pijls NH, van Son JA, Kirkeeide determining maximum coronary, flow by pressure measurements RL, et al. Experimental basis of myocardial, and collateral blood for assessing functional stenosis severity before and after percutaneous transluminal coronary an- gioplasty[J]. Circulation, 1993, 87(4): 1354-1367.
  • 9The BARID Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease [J]. N Engl J Med, 2009, 360(24): 2503-2515.
  • 10Dagenais GR, Lu J, Faxon DP, et al. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease [J]. Circulation, 2011, 123(14): 1492-1500.

引证文献6

二级引证文献37

;
使用帮助 返回顶部